Healthcare CRM Market Impressive Gains by 2022-2030

According to precedence research, the global healthcare CRM market size was USD 10.92 Billion in 2021 and is expected to reach USD 35.74 Billion by 2030 and register a revenue CAGR of 14.1% during the forecast period, 2022-2030.

Healthcare customer relationship management services provide a wide variety of tools and services to the customer who will further optimize and improve communication between patients and healthcare providers. Also, these tools comprise of messaging services, text messages, comment forms, online forms, and emails and these services and tools are further becoming more and more popular everywhere around the world. In addition, various healthcare organizations use these channels of CRM. As these tools aids them to minimize their manpower in order to minimize risk of errors, achieve profitability, and optimize the overall channels of communication. Also, marketing automation, sales force automation, and service automation are the key features of healthcare CRM system. Healthcare customer relationship management system is utilized in public clinic, hospitals, private clinic, and various research laboratories.

Download Exclusive Sample of Report@ https://www.precedenceresearch.com/sample/1602

Surge in demand for healthcare customer relationship management from patients in order to get easy approach for the treatments by virtual patient care mode, monitoring of mobile, home care, and counseling regarding diseases propels the growth of the global market. Major players such as Salesforce.Com Inc, IBM, and SAP SE are adopting various marketing techniques and key developmental strategy like partnership in order to improvise healthcare CRM products service portfolio. For instance, in the year 2018, the company named IBM came into a partnership with the key plyer named salesforce. This partnership brought along Salesforce Quip and Salesforce Service cloud Einstein  from Watson and Cloud services from IBM in order to aid organizations to coordinate with customers more effectively.

CRM is a platform of software which is further used to address various healthcare challenges that have grown due to the pandemic. The outbreak of COVID-19 had an immense positive impact on the market growth of global healthcare CRM due to raised awareness regarding healthcare systems, and efficient healthcare systems for patients.

Report Scope of the Healthcare CRM Market

Report Coverage Details
Market Size by 2030 USD 35.74 Billion
Growth Rate from 2022 to 2030 CAGR of 14.1%
North America Market Share in 2020 30%
Customer Service & Support Segment Market Share in 2020 25%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Component, End Use, Deployment Model, Application, Geography

Segments Analysis

Component Insights

Based on the component, growing overall spending on healthcare expenditure, which is leading to rise in adoption of healthcare CRM software for effective hospital services and management drives the market growth of the healthcare CRM and makes software the dominating segment of the market. In addition, according to the statistics of U.S. Government, the healthcare expenditure in the U.S. increased by 4.5% from the years 2018 to 2019.

However, the services segment is estimated to be the fastest growing segment during the forecast period. Owing to the growing requirement of new services in the health care segment like that can improve and optimize communication between healthcare providers and patients. These tools include messaging services, text messages, online forms, emails and comment forms.

Purchase this report (Price 4500 USD for a single-user license) @ https://www.precedenceresearch.com/checkout/1602

Application Insights

Customer service & support segment has generated a revenue share of more than 25% and dominated the global health care CRM market in 2020. However, the marketing segment is expected to be the fastest-growing segment during the forecast period. The moderate investment, higher profitability, and ease of operations have significantly boosted the growth of the marketing segment of health care CRM across the globe.

Region Insights

North America was the leading region for health care CRM market and has garnered a market share of more than 30% in 2020. North Americas will be a significant competitor in the global healthcare CRM market with its large pool of established payers, hospitals, and rising healthcare CRM usage. A considerable number of hospitals can be found in the region, and they would thus support the market growth. There are numerous challenges associated with the global healthcare CRM market. One of the most vital development factors is the high competition in the area. Owing to the evolution of the North America region healthcare infrastructure, the healthcare CRM market will progressively see a growing demand.

Asia-Pacific is considered as the fastest growing region in the global health care industry owing to the rising investors’ interest in the industry. The market is further becoming more transitional, driving these companies to establish operations in emerging markets such as India. This rise in the number of hospitals would require installing computerized records systems and other software to simplify the processes and therefore be attributed to market growth. Yet, the developing nations invest a substantial significance in erecting their domestic healthcare infrastructure. This development is anticipated to attract numerous investors and goad the development of the nation’s industry.

Some of the prominent players in the global health care CRM market include:

  • Salesforce.Com Inc
  •  Microsoft Corporation
  • Oracle Corporation
  • PegasystemsInc
  • Sage Group Plc
  • SAP SE
  • SugarCRM
  • Zoho Corporation Pvt Ltd
  • Cerner Corporation
  • Keona Health

Segments Covered in the Report

By Component

  • Software
  • Services

By Application

  • Customer Service & Support
  • Marketing
  • CRM Analytics
  • Others

By Deployment Model

  • On-Premise
  • Hybrid
  • Cloud

By End User

  • Healthcare Providers
    • Hospitals
    • Ambulatory Care Centers
    • Diagnostics & Imaging Centers
    • Pharmacies
    • Others
  • Healthcare Payers
    • Private Payers
    • Public Payers

Regional Segmentation

Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia],
Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland],
North America [United States, Canada, Mexico],
South America [Brazil, Argentina, Columbia, Chile, Peru].
Middle East & Africa [GCC, North Africa, South Africa],

Why should you invest in this report?

If you are aiming to enter the global xxx market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for xxx market are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

 Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare CRM Market 

5.1. COVID-19 Landscape: Healthcare CRM Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare CRM Market, By Component

8.1. Healthcare CRM Market, by Component Type, 2022-2030

8.1.1. Software

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Services

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Healthcare CRM Market, By Application

9.1. Healthcare CRM Market, by Application, 2022-2030

9.1.1. Customer Service & Support

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Marketing

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. CRM Analytics

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Healthcare CRM Market, By Deployment Model

10.1. Healthcare CRM Market, by Deployment Model Type, 2022-2030

10.1.1. On-Premise

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Hybrid

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Cloud

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Healthcare CRM Market, By End User Type 

11.1. Healthcare CRM Market, by End User Type, 2022-2030

11.1.1. Healthcare Providers

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Healthcare Payers

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Healthcare CRM Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Component (2017-2030)

12.1.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.1.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.2.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.3.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.4.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Deployment Model Type (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End User Type (2017-2030)

Chapter 13. Company Profiles

13.1. Salesforce.Com Inc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Microsoft Corporation

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Oracle Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. PegasystemsInc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Sage Group Plc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. SAP SE

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. SugarCRM

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Zoho Corporation Pvt Ltd

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Cerner Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Keona Health

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Buy Exclusive Report@ https://www.precedenceresearch.com/checkout/1602

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com